Alzheimer's "Prevention" vs. "Risk Reduction": Transcending Semantics for Clinical Practice

Area of Science:

• Neurology
• Geriatrics
• Medical Semantics

Background:

• The terms "prevention" and "risk reduction" are frequently used interchangeably in medical contexts.
• Significant debate exists regarding their application to interventions aimed at preserving cognitive health or delaying Alzheimer's disease (AD) progression.
• Clear distinctions between Alzheimer's disease prevention and Alzheimer's dementia prevention are needed.

Purpose of the Study:

• To explore the semantics and appropriate clinical use of
• prevention
• " and "risk reduction" in relation to Alzheimer's disease.
• To address the lack of clear clinical consensus criteria for physicians regarding these terms.
• To guide clinical practice and research by clarifying the implications of each term.

Main Methods:

• Literature review and semantic analysis of
• prevention
• and
• risk reduction
• in the context of Alzheimer's disease.
• Exploration of existing research criteria for Alzheimer's disease stages.
• Analysis of clinical practice implications.

Main Results:

• Prior studies have established criteria for Alzheimer's disease progression stages.
• No clear clinical consensus criteria currently exist to guide physicians in using
• prevention
• and
• risk reduction
• for Alzheimer's disease.
• The distinction between disease and dementia prevention requires careful consideration.

Conclusions:

• Clarifying the precise meaning and application of
• prevention
• and
• risk reduction
• is essential for effective Alzheimer's disease clinical care.
• A shared understanding will improve clinical decision-making and research direction.
• Further development of consensus criteria is recommended for clinical practice.